Norwalk set to vote on COVID-19 vaccine agreement

Photo of Abigail Brone
(FILES) In this file photo taken on November 18, 2020 shows a syringe and a bottle reading

(FILES) In this file photo taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - US firm Moderna said it would file requests for emergency authorization of its Covid-19 vaccine in the United States and Europe on November 30, 2020, after full results confirmed a high efficacy estimated at 94.1 percent. "We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death," said the company's CEO Stephane Bancel. (Photo by JOEL SAGET / AFP) / -- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE -- (Photo by JOEL SAGET/AFP via Getty Images)

JOEL SAGET / AFP via Getty Images

NORWALK — The Common Council is expected to vote at a special meeting Monday night on allowing the city to agree to a COVID-19 vaccination program.

Approving the Centers for Disease Control COVID-19 Vaccination Program Provider Agreement means the city and health department are able to receive the virus vaccines when they become available in the coming weeks, Mayor Harry Rilling said.

“We want to be ready to be able to begin vaccinating the public as soon as possible,” Rilling said Monday.

Pfizer is set to present its vaccine before the Food and Drug Administration on Dec. 10 and drugmaker Moderna will present its version on Dec. 17. Once a vaccine is approved, the city will begin finalizing a distribution plan, Rilling said.

As part of the agreement, the city must meet certian regulations regarding vaccine distribution and storage, recording of averse reactions to the vaccine and preservation of any COVID-19 vaccine related records, according to the provider agreement.

Each location that will be adminsitering the vaccine is required to identify the age and type populations it provides for in the application.

Under the agreement, providers are required to supply the vaccine to the population the provider serves “regardless of the vaccine recipient’s ability to pay COVID-19 Vaccine administration fees.” Providers are also barred from selling or seeking reimbursement for the vaccine, according to the aggreement.

“It allows us to be prepared and receive the vaccine,” Rilling said. “In the agreement with the CDC there is no doubt we will be receiving some of the vaccines and we want to get in line quickly.”

abigail.brone@hearstmediact.com